DUCHENNE WITH
CORTICOSTEROIDS
Corticosteroids are medicines that help to treat inflammation
The American Academy of Neurology and the U.S. Centers for Disease Control and Prevention recommend corticosteroids as part of Duchenne treatment
The CDC guidelines recommend that boys with DMD begin corticosteroid therapy before they show substantial physical decline
DISCUSS CORTICOSTEROIDS WITH YOUR TEAM
Before beginning treatment with corticosteroids, you should discuss the benefits and risks of treatment with your child's care team. Download our Doctor Discussion Guide to help you prepare for your child‘s next appointment (see PDF page 12).
THE BENEFITS OF STARTING TREATMENT EARLY WITH A CORTICOSTEROID LIKE EMFLAZA® BEFORE A CHILD SHOWS PHYSICAL DECLINE HAVE BEEN ESTABLISHED IN CLINICAL STUDIES
Updated treatment guidelines identify EMFLAZA as a recommended treatment option for Duchenne muscular dystrophy. EMFLAZA is the first and only FDA-approved corticosteroid for Duchenne muscular dystrophy.
The EMFLAZA molecule is different from other corticosteroids and was developed to provide a more tolerable treatment option